Dr Howard Hodis
Professor of Medicine and Preventive Medicine and Director of the Atherosclerosis Research Unit, Keck School of Medicine at the University of Southern California in Los Angeles.
Dr Hodis explains indications and risk factors for the new class of lipid-lowering drugs. In addition, he discusses the gender differences in cardiovascular disease.
Content updated 20 May 2018